FDA product code NIA: Assay, Direct, Nucleic Acid Amplification, Influenza Virus

NIA is the FDA product code for assay, direct, nucleic acid amplification, influenza virus. It is a Class I device, regulated under 21 CFR 866.3330 and reviewed by the Microbiology panel. Devices under NIA reach the market by 510(k); FDA lists no cleared 510(k)s for it.

Definition

These reagents are nucleic acid primers and probes for the amplification and identification of Influenza virus directly from clinical specimens. The identification aids in the diagnosis of influenza and provides epidemiological information on this disease. This reagent differs from the description in the regulation in that it consists of nucleic acid primers and probes rather than antisera.

Classification

FieldValue
Device nameAssay, Direct, Nucleic Acid Amplification, Influenza Virus
Device classClass I
Regulation21 CFR 866.3330
Review panelMI — Microbiology
Medical specialtyMicrobiology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Recalls for NIA devices

FDA recall records list no recalls for product code NIA.

HCPCS codes with matching descriptors

Text match between the FDA device name and CMS descriptors, not an official crosswalk:

Frequently asked questions

What is FDA product code NIA?

NIA is the FDA product code for assay, direct, nucleic acid amplification, influenza virus. It is a Class I device, regulated under 21 CFR 866.3330 and reviewed by the Microbiology panel.

What device class is NIA?

Class I, regulation 21 CFR 866.3330. Typical premarket route: 510(k).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times